text
text
text
text

About Us

Drug Discovery Platforms img-2-1
ImmuneAge Bio

Our rejuvenation technology stems from pinoneering work in our founders’ labs at the University of Lausanne, Switzerland and the University of Oxford, UK. We have over 100 years combined expertise in drug discovery and are joined by world leaders in immune aging.

Cell Rejuvenation img-1
Our Mission

We rejuvenate the bone marrow stem cells (hematopoietic stem cells or HSCs) and other immune cell types, to prevent aging and treat many different diseases. Our approach may revolutionize the treatment of cancer, infectious disease, cardiovascular disease, and brain aging — the immune system governs aging at a systemic level.